Parinita Agrawal

Dr. Parinita Agrawal


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2016 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
PAParinita Agrawal
Parinita Agrawal
KPKrishna Pramanik
Krishna Pramanik

29 September 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
PAParinita Agrawal
Parinita Agrawal
KPKrishna Pramanik
Krishna Pramanik
ABAmit Biswas
Amit Biswas
RPRanjan Ku Patra
Ranjan Ku Patra

13 January 2018 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
PAParinita Agrawal
Parinita Agrawal
KPKrishna Pramanik
Krishna Pramanik
VVVarshini Vishwanath
Varshini Vishwanath
ABAmit Biswas
Amit Biswas
ABAkalabya Bissoyi
Akalabya Bissoyi
PPPradeep Kumar Patra
Pradeep Kumar Patra

2 April 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
ACArun Chandru
Arun Chandru
PAParinita Agrawal
Parinita Agrawal
SOsanjay ojha
sanjay ojha
Kamalnath SelvakumarKamalnath Selvakumar
Kamalnath Selvakumar
VSVaishnavi K. Shiva
Vaishnavi K. Shiva
VSVivek Singh
Vivek Singh
Biological materials derived from extracellular matrix (ECM) proteins have garnered interest as their composition is very similar to that of native tissue. Herein, we report the use of human cornea derived decellularized ECM (dECM) microparticles dispersed in human fibrin sealant as an accessible therapeutic alternative for corneal anterior stromal reconstruction. dECM microparticles had good particle size distribution (≤10 µm) and retained the majority of corneal ECM components found in native tissue. Fibrin–dECM hydrogels exhibited compressive modulus of 70.83 ± 9.17 kPa matching that of native tissue, maximum burst pressure of 34.3 ± 3.7 kPa, and demonstrated a short crosslinking time of ~17 min. The fibrin–dECM hydrogels were found to be biodegradable, cytocompatible, non-mutagenic, non-sensitive, non-irritant, and supported the growth and maintained the phenotype of encapsulated human corneal stem cells (hCSCs) in vitro. In a rabbit model of anterior lamellar keratectomy, fibrin–dECM bio-adhesives promoted corneal re-epithelialization within 14 days, induced stromal tissue repair, and displayed integration with corneal tissues in vivo. Overall, our results suggest that the incorporation of cornea tissue-derived ECM microparticles in fibrin hydrogels is non-toxic, safe, and shows tremendous promise as a minimally invasive therapeutic approach for the treatment of superficial corneal epithelial wounds and anterior stromal injuries.

1 July 2018 in Regenerative Medicine
Verified
Journal Article
Closed access
PAParinita Agrawal
Parinita Agrawal
KPKrishna Pramanik
Krishna Pramanik
ABAmit Biswas
Amit Biswas
Aim: Cartilage damage is a common age-related problem that leads to progressive proteoglycan loss. Glucosamine stimulates proteoglycan synthesis and, therefore, its effect on the cartilage extracellular matrix synthesis over silk fibroin:chitosan (SF:CS) tissue-engineered scaffold was investigated for cartilage construct generation. Materials & methods: Human mesenchymal stem cells (hMSCs) were cultured and differentiated over SF:CS-glucosamine porous scaffold, under dynamic culture condition in spinner flask bioreactor.Results: hMSCs-seeded scaffold in dynamic culture exhibited homogenous cell distribution, proliferation and higher cell density at the core than static culture. Glucosamine in scaffold promoted proteoglycan and collagenous matrix synthesis as revealed by histological and immunofluorescence studies. Quantitative-PCR analysis showed upregulation of cartilage-specific genes, thereby confirming the chondrogenic differentiation. Conclusion: The chondrogenic differentiation of hMSCs was enhanced...